HomeNewsIndiaThere will be changes in the way judicial systems function, post COVID-19: Raian Karanjawala

There will be changes in the way judicial systems function, post COVID-19: Raian Karanjawala

Raian Karanjawala, founder of one of the most influential law firms in the country, says clients and lawyers will now look at videoconferencing as a means of saving time and effort. When things settle down, there will be a 20–25% change in the way things are functioning, he adds

October 27, 2021 / 12:36 IST
Story continues below Advertisement
Raian Karanjawala feels that post COVID-19, will be an amalgamation of touchy-feely kind of litigation and the new smart work, ‘Zoom call habit’ that has now come into practice. (Image Source: Shutterstock)
Raian Karanjawala feels that post COVID-19, will be an amalgamation of touchy-feely kind of litigation and the new smart work, ‘Zoom call habit’ that has now come into practice. (Image Source: Shutterstock)

Raian Karanjawala is the managing partner of New Delhi-based Karanjawala & Co. It’s a law firm he founded with his wife Manik in the early eighties, from a barsati of his father-in-law’s house in Maharani Bagh with two desks. (Barsati is a one-room apartment on the terrace with a veranda outside.)

Today, his firm is one of the most influential in the country, with over 150 employees on the payroll and three offices in Delhi, serving everyone — from governments and companies in trouble, to celebrities and street vendors in distress; earning him in the process, the nickname, ‘the big picture guy’.

Story continues below Advertisement

In an interview to Moneycontrol, Karanjawala talks about the new challenges and opportunities before the Indian justice system and court administration in the wake of COVID-19.

How different do you think the impact of the COVID-19 pandemic will be from the global financial crisis of 2007-2008?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show